External validation of the VENUSS prognostic model to predict recurrence after surgery in non-metastatic papillary renal cell carcinoma: A multi-institutional analysis


ERDEM S., Capitanio U., Campi R., Mir M. C., Roussel E., Pavan N., ...More

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, vol.40, no.5, 2022 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 40 Issue: 5
  • Publication Date: 2022
  • Doi Number: 10.1016/j.urolonc.2022.01.006
  • Journal Name: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
  • Keywords: Disease recurrence after curative surgery, Non-metastatic, Papillary renal cell carcinoma, Validation, VENUSS Prognostic model, CLEAR-CELL, TYPE-1, NOMOGRAM, SURVIVAL, OUTCOMES, TRIAL
  • Kocaeli University Affiliated: No

Abstract

Objective: Recently, VENUSS (VEnous extension, NUclear Grade, Size, Stage), as a prognostic model, was defined to predict disease recurrence (DR) after curative surgery of non-metastatic papillary renal cell carcinoma (papRCC). This study aimed to validate the VENUSS prognostic model in a large multi-institutional European cohort of patients with histopathologically proven papRCC after curative surgery for non-metastatic disease.